Global Neurovascular Devices
Market Report
2024
Neurovascular Devices Market Report 2024 (Global Edition)
Neurovascular devices market was valued at USD 3.42 billion in 2022 and will reach USD 6.42 billion by 2030, registering a CAGR of 5.5% for the forecast period 2023-2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Neurovascular Devices Market Report 2024.
Global Neurovascular Devices Market Report 2024 Market Size Split by Device Type (Neurothrombectomy Devices, Neurovascular Embolization Devices, Cerebral Balloon Angioplasty and Stenting Systems, Supp...
The global neurovascular devices market was valued at USD 3.42 billion in 2022 and will reach USD 6.42 billion by 2030, registering a CAGR of 5.5% for the forecast period 2023-2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Neurovascular Devices Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.2% |
| Market Split by Device Type |
|
| Market Split by Application/Target Disease |
|
| Market Split by End-User |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Neurovascular Devices industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Neurovascular Devices Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Neurovascular Devices Market Report Description
Neurovascular devices are used to treat neurovascular diseases such as brain aneurysms. Including stenting systems, embolization devices, and neurothrombectomy devices. A neurovascular disease is a condition that has an impact on the spinal cord or brain's blood flow. Narrowing, hardening, or abnormalities of the blood arteries can all have an impact on blood flow. An obstruction brought on by a clot or embolism. A haemorrhage or bleeding due to a blood vessel rupture.
The rise in the prevalence of neurovascular diseases such as brain/cerebral aneurysms, strokes, and epilepsy among many others is a major driver propelling the market for neurovascular devices. Furthermore, increasing awareness of minimally invasive surgical procedures, strategic collaboration and partnership among manufacturers, technological advancement and development in neurovascular devices are fueling the market growth.
Driving factors:
- Increasing prevalence of neurovascular diseases:
AVMs, brain aneurysms, carotid artery disease, and intracranial atherosclerotic disease are just a few neurovascular conditions significantly affecting the global population's health and economy. These conditions can also lead to a variety of neurological issues, including subarachnoid hemorrhage, stroke, disability, and even death. Ischemic stroke is the more common type of neurovascular disorder.
According to, American Heart Association, when blood arteries in the brain burst and bleed, ICH strokes happen. They make up about 10% to 15% of the estimated 795,000 strokes that occur in the United States each year, making them the second most prevalent form. In 2020, there were 18.9 million intracerebral hemorrhages worldwide, according to the AHA's most current report on heart and stroke statistics. Compared to other forms of stroke, they are more lethal and more likely to result in long-term impairment.
Furthermore as per the Brain Aneurysm Foundation, In the US, 1 in 50 persons, or approximately 6.7 million people, have an unruptured cerebral aneurysm. Approximately 8 to 10 ruptures per 100,000 persons occur each year. In the United States, a brain aneurysm ruptures in around 30,000 people yearly. Every 18 minutes, a brain aneurysm bursts. Half of the victims of brain aneurysms annual fatalities in the globe are people under the age of 50.
- Technological advancement in neurovascular devices:
Neurovascular devices used in neurovascular disease treatment have undergone numerous advancements in recent years. The surgical field of neurovascular surgery uses a lot of technology, and many significant improvements in operative neurovascular surgical methods have been made before new technologies. For instance, when performing minimally invasive surgical procedures for neurovascular disorders, the ability to use computer-assisted neurosurgery provides the highest level of precision in planning and execution. Significant advancements in the detection and treatment of neurovascular disease have been accomplished. New technologies are receiving more and more attention from the industry as neurovascular device improvements continue to materialize. Balloon guide catheters, artificial intelligence (AI), virtual augmented reality, and robotic-assisted navigation all have specific advantages
The launch of new products and the increasing interest of competitors in this industry is expected to boost the growth of neurosurgical devices. For instance, in February 2022, Johnson & Johnson (CERENOVUS) Launched EMBOGUARD™ Balloon Guide Catheter to Use in the Treatment of Acute Ischemic Stroke.
Restraining factors:
- High cost and complications associated with surgical devices:
The cost of procedures for patients increases due to the high cost of neurovascular devices and the significant investment needed for installation. This has caused customers to switch to secondhand systems, which negatively affects their bottom lines. Complex surgeries require advanced techniques and skills, and equipment and surgery costs increase due to maintenance and power supply requirements.
Neurosurgery complications include aneurysm rupture, arterial dissection, stroke, hemorrhage, thromboembolism, and microembolism, and rates of neurologic deficit are higher than diagnostic angiography. The high cost and complications associated with surgeries can decrease the demand for neurovascular devices.
Impact of COVID- 19 pandemic on the neurovascular devices market:
During the COVID-19 pandemic period, all healthcare professionals and patients are affected. COVID-19 influenced the supply chain, product, and service delivery due to the lockdown. The COVID-19 pandemic greatly influenced not just the infected patients but also other people worldwide, particularly in underdeveloped nations and their healthcare systems. Global healthcare systems were significantly damaged by the COVID-19 epidemic.
Due to this circumstance, surgeries had to be postponed to manage and reserve resources, and many hospitals were unable to find qualified staff to help with these operations. A directive from the Indian government instructs medical providers to counsel patients to weigh the advantages and disadvantages of postponing surgery. Owing to the spread of COVID virus government, restrict the supply chain of goods and people therefore the sale of neurovascular devices is decreases. Consequently, the pandemic has harmed market expansion.
We have various report editions of Neurovascular Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Recent developments:
- April 2023
TeraRecon, a ConcertAI company, has introduced Neuro Suite, an advanced clinical suite powered by artificial intelligence (AI).
TeraRecon from ConcertAI, the market leader in the advanced visualization and clinical AI SaaS categories, has announced the launch of Neuro Suite, an AI-driven clinical suite. The Neuro Suite is intended to integrate across the entire healthcare organization and address challenges that clinicians face when making decisions regarding chronic neurological care. It was specifically created for disease triage, differential diagnostic insights, and care activation in many neurological disease states, including neuro-oncology, dementia, multiple sclerosis, and more.
- December 2022
Stryker launched a state-of-the-art Neurovascular R&D lab with advanced technology to accelerate stroke care innovation
One of the world's top medical equipment manufacturers, Stryker, recently introduced its Neurovascular (NV) lab, a cutting-edge facility created to spur innovation in stroke treatment in the Asia Pacific region. The Keystone Suite, which is a part of the Stryker Global Technology Center (SGTC) in Gurgaon, India, will promote communication between customers, product development engineers, cross-functional teams, and other important stakeholders.
- November 2022
Collaboration between Viz.ai and Vastrax to Speed up Clinical Trial Enrollment
The top full-service vascular clinical research organization (CRO), Vastrax, has announced a strategic relationship with Viz.ai, the pioneer in AI-powered illness identification and intelligent care coordination. Viz.ai and Vastrax will work together to speed up the enrolment in clinical trials for studies on cutting-edge neurovascular therapeutics.
- October 2022
Announced the launch of Medtronic Neurovascular Co-Lab™ Platform to accelerate innovation in stroke treatment
Medtronic plc, a global leader in healthcare technology, announced the launch of the Medtronic Neurovascular Co-Lab Platform, designed to accelerate urgently needed innovation in stroke care and treatment.
- September 2022
Shionogi & Co. Ltd., Shionogi Healthcare & Co. Ltd., and Pixie Dust Technologies Inc. entered into a collaboration agreement.
Shionogi & Co., Ltd., Shionogi Healthcare & Co., Ltd., and Pixie Dust Technologies, Inc. announced their business collaboration agreement to start a company that uses sound stimulation to activate the brain.
- February 2022
Johnson & Johnson (CERENOVUS) Launched EMBOGUARD™ Balloon Guide Catheter to Use in the Treatment of Acute Ischemic Stroke
The launch of EMBOGUARDTM, a new generation balloon guide catheter for use in endovascular treatments, including those for patients with acute ischemic stroke, was announced by CERENOVUS, a growing leader in neurovascular care and a division of Johnson & Johnson Medical Devices Companies. The EMBOGUARD™ Balloon Guide Catheter is designed to optimize the removal of clots by controlling blood flow locally during the mechanical thrombectomy (MT) procedure
Top Companies Market Share in Neurovascular Devices Industry: (In no particular order of Rank)
- Stryker Corporation
- Medtronic
- Boston Scientific
- Johnson & Johnson
- GE HealthCare
- DePuy Synthes Companies
- MicroPort Scientific Corporation
- Acandis GmbH
- MicroVention
- Inc.
- NeuroVasc Technologies
- Inc.
- Terumo Corporation
- Penumbra Inc.
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America held the largest revenue market share over the other regions in the global neurovascular devices market:
North America is accounted largest revenue market share compared to the Asian Pacific and Europe. Various factors are the reason for the increasing demand for the neurovascular devices markets in North America such as the rising prevalence of various neurovascular disorders such as ischemic strokes, cerebral aneurysms, arteriovenous malformation, and others in the region. Neurovascular devices play a significant role in the diagnosis of various neurovascular diseases such as ischemic strokes, cerebral aneurysms, and others. The United States has a high number of neurological conditions such as ischemic strokes. Therefore, there is an increasing demand for neurovascular devices for the diagnosis of such diseases. The rising diagnosis and treatment rate for these diseases further encourages the demand for minimally invasive neurovascular devices in the region thus providing a significant opportunity in the market.
The high incidence of neurological disorders rises the demand for accurate diagnosis and plans of efficient and on-time treatment by the healthcare provider. The sector is well known for adopting new technology more quickly to better service the big patient base. North American regions are adopting different strategies, such as acquisitions, partnerships, mergers, partnerships, and strengthening distribution networks to fuel their growth and expansion of the market.
The current report Scope analyzes Neurovascular Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Neurovascular Devices Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!
Neurovascular Devices Market Analysis
Global Neurovascular Devices Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Neurovascular Devices Industry growth. Neurovascular Devices market has been segmented with the help of its Device Type, Application/Target Disease End-User, and others. Neurovascular Devices market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
The neurothrombectomy devices segment accounted for the largest revenue share of the neurovascular devices market:
The type of device segments market into neurothrombectomy devices, neurovascular embolization devices, cerebral balloon angioplasty, stenting systems, support devices, aneurysm coiling, and others. In which neurothrombectomy devices held the largest share of the market.
The Food and Drug Administration (FDA) defines a neurothrombectomy device as one that uses mechanical, laser, ultrasound, or a combination of technologies to remove or dissolve blood clots from the cerebral neuro vasculature. Acute ischemic strokes are linked to poor prognoses and significant medical costs. There is research examining the use of neurothrombectomy tools in individuals undergoing presently advised therapies.
Compared to pharmacologic thrombolysis, neurothrombectomy devices provide many potential benefits, such as faster recanalization, improved effectiveness in treating large-vessel occlusions, and maybe a decreased risk of haemorrhagic complications.
Neurovascular Devices Market Share (%) by Device Type in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Neurovascular Devices Industry. Request a Free Sample PDF!
Ischemic strokes dominated the worldwide neurovascular devices market revenue share:
The market is segmented by application into ischemic strokes, cerebral aneurysms, arteriovenous malformation, and other target diseases. In which ischemic strokes held the largest share of the market.
Ischemic stroke is the more common type of neurovascular disorder. A blood clot that stops or plugs a blood artery in the brain is often the culprit. This prevents the brain from receiving blood flow. Brain cells start to degenerate in minutes. Stenosis, or arterial narrowing, is another factor. When a blood artery that supplies the brain with oxygen and nutrients is blocked, an ischemic stroke is caused. The main cause of ischemic stroke is atherosclerosis, or fatty deposits (plaque) that line the vessel walls. According to CDC, About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked. Therefore as the prevalence of ischemic stroke increases, the demand for neurovascular devices increases.
Neurovascular Devices Market Share (%) by Application/Target Disease in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Neurovascular Devices market report 2024 Edition by contacting our team.
Neurovascular Devices End-User Segment Analysis
The hospital segment captures the largest revenue share of the neurovascular devices market:
End users segment the market into hospitals, specialty care centers, ambulatory centers, research laboratories, and academic institutions. In which hospitals held the largest share of the market.
The neurovascular surgery process is used widely in hospitals because of the rising cases of neurovascular disorders and the increasing demand for surgeries. In hospitals, highly qualified healthcare personnel are present to monitor the health condition of patients, together with the availability of various neurovascular surgery devices and medical technology is fueling the expansion of this market. Hospitals also serve a larger patient base and can handle complicated treatments, all of that is contributing to the neurovascular device industry's expansion in this market category.
- Hospitals
- Specialty care centers
- Ambulatory centers
- Research laboratories
- Academic institutions
Author's Detail
Anushka GoreResearch Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses
I played a pivotal role in conducting market research and competitive analysis. I have a demonstrated ability to synthesize diverse data sources, identify trends, and translate findings into actionable recommendations. My collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization. I am committed to maintaining excellence through continuous learning and staying ahead of industry trends. Regular participation in conferences and professional development opportunities keeps my skills sharp and relevant.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Neurovascular Devices Market is witnessing significant growth in the near future.
In 2023, the Neurothrombectomy Devices segment accounted for noticeable share of global Neurovascular Devices Market and is projected to experience significant growth in the near future.
The Ischemic Strokes segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Stryker Corporation , Boston Scientific and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions
Latest News about Neurovascular Devices Market
- http://www.trade.gov
- http://www.gov.uk
- http://www.fda.gov
- http://www.hhs.gov
- http://www.who.int
- http://www.bls.gov
- http://www.gao.gov
- http://www.ncbi.nlm.nih.gov
- http://www.healthcaredive.com
- http://www.export.gov
- http://www.weforum.org
- http://www.health.gov.za
- http://www.usaid.gov
- http://www.eumdr.com
- http://www.cdc.gov
- http://www.ama-assn.org
- http://www.washingtonpost.com
- http://www.ecfr.gov
- http://www.hbr.org
- http://www.worldbank.org
- http://www.commission.europa.eu
- http://www.cbi.eu
- http://www.unicef.org
- http://www.ecipe.org
- http://www.ema.europa.eu
Neurovascular Devices Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Device Type | Neurothrombectomy Devices, Neurovascular Embolization Devices, Cerebral Balloon Angioplasty and Stenting Systems, Support Devices, Aneurysm Coiling, Others |
| Application/Target Disease | Ischemic Strokes, Cerebral Aneurysms, Arteriovenous Malformation, Other diseases |
| End-User | Hospitals, Specialty care centers, Ambulatory centers, Research laboratories, Academic institutions |
| List of Competitors | Stryker Corporation, Medtronic, Boston Scientific, Johnson & Johnson, GE HealthCare, DePuy Synthes Companies, MicroPort Scientific Corporation, Acandis GmbH, MicroVention, Inc., NeuroVasc Technologies, Inc., Terumo Corporation, Penumbra Inc. |
This chapter will help you gain GLOBAL Market Analysis of Neurovascular Devices. Further deep in this chapter, you will be able to review Global Neurovascular Devices Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Neurovascular Devices Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Neurovascular Devices Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Neurovascular Devices Revenue Market Size By Region
-
-
1.3 Global Neurovascular Devices Market Size By Device Type 2019 -2031
-
1.3.1 Neurothrombectomy Devices Market Size
-
1.3.2 Neurovascular Embolization Devices Market Size
-
1.3.3 Cerebral Balloon Angioplasty and Stenting Systems Market Size
-
1.3.4 Support Devices Market Size
-
1.3.5 Aneurysm Coiling Market Size
-
1.3.6 Others Market Size
-
-
1.4 Global Neurovascular Devices Market Size By Application/Target Disease 2019 -2031
-
1.4.1 Ischemic Strokes Market Size
-
1.4.2 Cerebral Aneurysms Market Size
-
1.4.3 Arteriovenous Malformation Market Size
-
1.4.4 Other diseases Market Size
-
-
1.5 Global Neurovascular Devices Market Size By End-User 2019 -2031
-
1.5.1 Hospitals Market Size
-
1.5.2 Specialty care centers Market Size
-
1.5.3 Ambulatory centers Market Size
-
1.5.4 Research laboratories Market Size
-
1.5.5 Academic institutions Market Size
-
-
1.6 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.7 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.7.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.7.2 Global Market Revenue Split By Device Type
-
1.7.3 Global Market Revenue Split By Application/Target Disease
-
1.7.4 Global Market Revenue Split By End-User
-
1.7.5 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Neurovascular Devices Market Size 2019 - 2031
-
2.1.1 North America Neurovascular Devices Market Size By Country 2019 - 2031
-
2.1.2 North America Neurovascular Devices Market Size by Device Type 2019 -2031
-
2.1.2.1 North America Neurothrombectomy Devices Market Size
-
2.1.2.2 North America Neurovascular Embolization Devices Market Size
-
2.1.2.3 North America Cerebral Balloon Angioplasty and Stenting Systems Market Size
-
2.1.2.4 North America Support Devices Market Size
-
2.1.2.5 North America Aneurysm Coiling Market Size
-
2.1.2.6 North America Others Market Size
-
-
2.1.3 North America Neurovascular Devices Market Size by Application/Target Disease 2019 -2031
-
2.1.3.1 North America Ischemic Strokes Market Size
-
2.1.3.2 North America Cerebral Aneurysms Market Size
-
2.1.3.3 North America Arteriovenous Malformation Market Size
-
2.1.3.4 North America Other diseases Market Size
-
-
2.1.4 North America Neurovascular Devices Market Size by End-User 2019 -2031
-
2.1.4.1 North America Hospitals Market Size
-
2.1.4.2 North America Specialty care centers Market Size
-
2.1.4.3 North America Ambulatory centers Market Size
-
2.1.4.4 North America Research laboratories Market Size
-
2.1.4.5 North America Academic institutions Market Size
-
-
-
2.2 Add-Ons: Customize the Report Edition
Purchase Add-Ons to Customize the Report Edition and get further granular data level data about the North America market. Add-On Cost: Request before placing the order, Respective Pricing will be informed after sending the inquiry
-
2.2.1 North America Company Market Share 2019 till 2023
-
2.2.2 Qualitative Analysis for North America Market
Qualitative Analysis for the North America Market: North America Neurovascular Devices Market Trends North America Neurovascular Devices Technological Road Map North America Neurovascular Devices Market Drivers North America Neurovascular Devices Market Restraints North America Neurovascular Devices Market Opportunity Market Attractiveness Analysis COVID – 19 Impact Analysis PESTEL Analysis Porter’s Five Forces Analysis Product Life Cycle Industrial Chain Analysis
-
-
2.3 Executive Summary North America Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary North America Market (2019 vs 2024 vs 2031)
-
2.3.1 North America Market Summary 2019 vs 2024 vs 2031
-
2.3.2 North America Market Revenue Split By Device Type
-
2.3.3 North America Market Revenue Split By Application/Target Disease
-
2.3.4 North America Market Revenue Split By End-User
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Neurovascular Devices Market Size 2019 - 2031
-
3.1.1 Europe Neurovascular Devices Market Size By Country 2019 - 2031
-
3.1.2 Europe Neurovascular Devices Market Size by Device Type 2019 -2031
-
3.1.2.1 Europe Neurothrombectomy Devices Market Size
-
3.1.2.2 Europe Neurovascular Embolization Devices Market Size
-
3.1.2.3 Europe Cerebral Balloon Angioplasty and Stenting Systems Market Size
-
3.1.2.4 Europe Support Devices Market Size
-
3.1.2.5 Europe Aneurysm Coiling Market Size
-
3.1.2.6 Europe Others Market Size
-
-
3.1.3 Europe Neurovascular Devices Market Size by Application/Target Disease 2019 -2031
-
3.1.3.1 Europe Ischemic Strokes Market Size
-
3.1.3.2 Europe Cerebral Aneurysms Market Size
-
3.1.3.3 Europe Arteriovenous Malformation Market Size
-
3.1.3.4 Europe Other diseases Market Size
-
-
3.1.4 Europe Neurovascular Devices Market Size by End-User 2019 -2031
-
3.1.4.1 Europe Hospitals Market Size
-
3.1.4.2 Europe Specialty care centers Market Size
-
3.1.4.3 Europe Ambulatory centers Market Size
-
3.1.4.4 Europe Research laboratories Market Size
-
3.1.4.5 Europe Academic institutions Market Size
-
-
-
3.2 Add-Ons: Customize the Report Edition
-
3.2.1 Europe Company Market Share 2019 till 2023
-
3.2.2 Qualitative Analysis for Europe Market
-
-
3.3 Executive Summary Europe Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Europe Market (2019 vs 2024 vs 2031)
-
3.3.1 Europe Revenue Market Summary 2019 vs 2024 vs 2031
-
3.3.2 Europe Market Revenue Split By Device Type
-
3.3.3 Europe Market Revenue Split By Application/Target Disease
-
3.3.4 Europe Market Revenue Split By End-User
-
Chapter 4 Asia-Pacific Market Analysis
-
4.1 Asia Pacific Neurovascular Devices Market Size 2019 - 2031
-
4.1.1 Asia Pacific Neurovascular Devices Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Neurovascular Devices Market Size by Device Type 2019 -2031
-
4.1.2.1 Asia Pacific Neurothrombectomy Devices Market Size
-
4.1.2.2 Asia Pacific Neurovascular Embolization Devices Market Size
-
4.1.2.3 Asia Pacific Cerebral Balloon Angioplasty and Stenting Systems Market Size
-
4.1.2.4 Asia Pacific Support Devices Market Size
-
4.1.2.5 Asia Pacific Aneurysm Coiling Market Size
-
4.1.2.6 Asia Pacific Others Market Size
-
-
4.1.3 Asia Pacific Neurovascular Devices Market Size by Application/Target Disease 2019 -2031
-
4.1.3.1 Asia Pacific Ischemic Strokes Market Size
-
4.1.3.2 Asia Pacific Cerebral Aneurysms Market Size
-
4.1.3.3 Asia Pacific Arteriovenous Malformation Market Size
-
4.1.3.4 Asia Pacific Other diseases Market Size
-
-
4.1.4 Asia Pacific Neurovascular Devices Market Size by End-User 2019 -2031
-
4.1.4.1 Asia Pacific Hospitals Market Size
-
4.1.4.2 Asia Pacific Specialty care centers Market Size
-
4.1.4.3 Asia Pacific Ambulatory centers Market Size
-
4.1.4.4 Asia Pacific Research laboratories Market Size
-
4.1.4.5 Asia Pacific Academic institutions Market Size
-
-
-
4.2 Add-Ons: Customize the Report Edition
-
4.2.1 Asia Pacific Company Market Share 2019 till 2023
-
4.2.2 Qualitative Analysis for Asia Pacific Market
-
-
4.3 Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Asia Pacific Market (2019 vs 2024 vs 2031)
-
4.3.1 Asia Pacific Market Summary 2019 vs 2024 vs 2031
-
4.3.2 Asia Pacific Market Revenue Split By Device Type
-
4.3.3 Asia Pacific Market Revenue Split By Application/Target Disease
-
4.3.4 Asia Pacific Market Revenue Split By End-User
-
Chapter 5 South America Market Analysis
-
5.1 South America Neurovascular Devices Market Size 2019 - 2031
-
5.1.1 South America Neurovascular Devices Revenue Market Size By Country 2019 - 2031
-
5.1.2 South America Neurovascular Devices Market Size by Device Type 2019 -2031
-
5.1.2.1 South America Neurothrombectomy Devices Market Size
-
5.1.2.2 South America Neurovascular Embolization Devices Market Size
-
5.1.2.3 South America Cerebral Balloon Angioplasty and Stenting Systems Market Size
-
5.1.2.4 South America Support Devices Market Size
-
5.1.2.5 South America Aneurysm Coiling Market Size
-
5.1.2.6 South America Others Market Size
-
-
5.1.3 South America Neurovascular Devices Market Size by Application/Target Disease 2019 -2031
-
5.1.3.1 South America Ischemic Strokes Market Size
-
5.1.3.2 South America Cerebral Aneurysms Market Size
-
5.1.3.3 South America Arteriovenous Malformation Market Size
-
5.1.3.4 South America Other diseases Market Size
-
-
5.1.4 South America Neurovascular Devices Market Size by End-User 2019 -2031
-
5.1.4.1 South America Hospitals Market Size
-
5.1.4.2 South America Specialty care centers Market Size
-
5.1.4.3 South America Ambulatory centers Market Size
-
5.1.4.4 South America Research laboratories Market Size
-
5.1.4.5 South America Academic institutions Market Size
-
-
-
5.2 Add-Ons: Customize the Report Edition
-
5.2.1 South America Company Market Share 2019 till 2023
-
5.2.2 Qualitative Analysis for South America Market
-
-
5.3 Executive Summary South America Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary South America Market (2019 vs 2024 vs 2031)
-
5.3.1 South America Market Summary 2019 vs 2024 vs 2031
-
5.3.2 South America Market Revenue Split By Device Type
-
5.3.3 South America Market Revenue Split By Application/Target Disease
-
5.3.4 South America Market Revenue Split By End-User
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Neurovascular Devices Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Neurovascular Devices Revenue Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Neurovascular Devices Market Size by Device Type 2019 -2031
-
6.1.2.1 Middle East and Africa Neurothrombectomy Devices Market Size
-
6.1.2.2 Middle East and Africa Neurovascular Embolization Devices Market Size
-
6.1.2.3 Middle East and Africa Cerebral Balloon Angioplasty and Stenting Systems Market Size
-
6.1.2.4 Middle East and Africa Support Devices Market Size
-
6.1.2.5 Middle East and Africa Aneurysm Coiling Market Size
-
6.1.2.6 Middle East and Africa Others Market Size
-
-
6.1.3 Middle East and Africa Neurovascular Devices Market Size by Application/Target Disease 2019 -2031
-
6.1.3.1 Middle East and Africa Ischemic Strokes Market Size
-
6.1.3.2 Middle East and Africa Cerebral Aneurysms Market Size
-
6.1.3.3 Middle East and Africa Arteriovenous Malformation Market Size
-
6.1.3.4 Middle East and Africa Other diseases Market Size
-
-
6.1.4 Middle East and Africa Neurovascular Devices Market Size by End-User 2019 -2031
-
6.1.4.1 Middle East and Africa Hospitals Market Size
-
6.1.4.2 Middle East and Africa Specialty care centers Market Size
-
6.1.4.3 Middle East and Africa Ambulatory centers Market Size
-
6.1.4.4 Middle East and Africa Research laboratories Market Size
-
6.1.4.5 Middle East and Africa Academic institutions Market Size
-
-
-
6.2 Add-Ons: Customize the Report Edition
-
6.2.1 Middle East and Africa Company Market Share 2019 till 2023
-
6.2.2 Qualitative Analysis for Middle East and Africa Market
-
-
6.3 Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary Middle East and Africa Market (2019 vs 2024 vs 2031)
-
6.3.1 Middle East and Africa Market Summary 2019 vs 2024 vs 2031
-
6.3.2 Middle East and Africa Market Revenue Split By Device Type
-
6.3.3 Middle East and Africa Market Revenue Split By Application/Target Disease
-
6.3.4 Middle East and Africa Market Revenue Split By End-User
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Neurovascular Devices Market Size by Device Type 2019 -2031
-
7.1.2 Country 1Neurovascular Devices Market Size by Application/Target Disease 2019 -2031
-
7.1.3 Country 1Neurovascular Devices Market Size by End-User 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Neurovascular Devices Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Stryker Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Medtronic
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Boston Scientific
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Johnson & Johnson
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 GE HealthCare
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 DePuy Synthes Companies
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 MicroPort Scientific Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 Acandis GmbH
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 MicroVention
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 NeuroVasc Technologies
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 Terumo Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
8.2.14 Penumbra Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.14.2 Business Overview
-
8.2.14.3 Financials (Subject to data availability)
-
8.2.14.4 Product Types Specification
-
8.2.14.5 Business Strategy
-
8.2.14.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Device Type Analysis 2019 -2031, will provide market size split by Device Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Device Type Analysis 2019 -2031
-
10.1 Neurothrombectomy Devices
-
10.1.1 Global Neurovascular Devices Revenue Market Size and Share by Neurothrombectomy Devices 2019 -2031
-
-
10.2 Neurovascular Embolization Devices
-
10.2.1 Global Neurovascular Devices Revenue Market Size and Share by Neurovascular Embolization Devices 2019 -2031
-
-
10.3 Cerebral Balloon Angioplasty and Stenting Systems
-
10.3.1 Global Neurovascular Devices Revenue Market Size and Share by Cerebral Balloon Angioplasty and Stenting Systems 2019 -2031
-
-
10.4 Support Devices
-
10.4.1 Global Neurovascular Devices Revenue Market Size and Share by Support Devices 2019 -2031
-
-
10.5 Aneurysm Coiling
-
10.5.1 Global Neurovascular Devices Revenue Market Size and Share by Aneurysm Coiling 2019 -2031
-
-
10.6 Others
-
10.6.1 Global Neurovascular Devices Revenue Market Size and Share by Others 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application/Target Disease Analysis 2019 -2031
-
11.1 Ischemic Strokes
-
11.1.1 Global Neurovascular Devices Revenue Market Size and Share by Ischemic Strokes 2019 - 2031
-
-
11.2 Cerebral Aneurysms
-
11.2.1 Global Neurovascular Devices Revenue Market Size and Share by Cerebral Aneurysms 2019 - 2031
-
-
11.3 Arteriovenous Malformation
-
11.3.1 Global Neurovascular Devices Revenue Market Size and Share by Arteriovenous Malformation 2019 - 2031
-
-
11.4 Other diseases
-
11.4.1 Global Neurovascular Devices Revenue Market Size and Share by Other diseases 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by End-User Analysis 2019 -2031
-
12.1 Hospitals
-
12.1.1 Global Neurovascular Devices Revenue Market Size and Share by Hospitals 2019 -2031
-
-
12.2 Specialty care centers
-
12.2.1 Global Neurovascular Devices Revenue Market Size and Share by Specialty care centers 2019 -2031
-
-
12.3 Ambulatory centers
-
12.3.1 Global Neurovascular Devices Revenue Market Size and Share by Ambulatory centers 2019 -2031
-
-
12.4 Research laboratories
-
12.4.1 Global Neurovascular Devices Revenue Market Size and Share by Research laboratories 2019 -2031
-
-
12.5 Academic institutions
-
12.5.1 Global Neurovascular Devices Revenue Market Size and Share by Academic institutions 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Neurovascular Devices market
Chapter 13 Research Findings
-
13.1 Key Takeaways
-
13.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
13.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Anushka Gore and Team
- 1.1 Neurovascular Devices Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Neurovascular Devices Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Neurovascular Devices Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Neurovascular Devices Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Neurovascular Devices Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Neurovascular Devices Market
Key Questions Answered By Neurovascular Devices Market Report 2024
| Why Neurothrombectomy Devices have a significant impact on Neurovascular Devices market? |
| What are the key factors affecting the Neurothrombectomy Devices and Neurovascular Embolization Devices of Neurovascular Devices Market? |
| What is the CAGR/Growth Rate of Ischemic Strokes during the forecast period? |
| By type, which segment accounted for largest share of the global Neurovascular Devices Market? |
| Which region is expected to dominate the global Neurovascular Devices Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
